Fox Chase Cancer Center News

PHILADELPHIA, PA (February 21, 2013)—Carol and Louis E. Della Penna Sr. of New Hope, PA, have made a $4 million commitment to Fox Chase Cancer Center establishing the Carol and Louis Della Penna Chair in Urologic Oncology and the Louis Della Penna Family Chair in Head and Neck Oncology.

PHILADELPHIA, PA (February 11, 2013)—Eighty-three (83) Temple physicians have been named to the Best Doctors in America^® list for 2013.  Only five percent of doctors in America earn a spot on the prestigious list compiled and published by Best Doctors, Inc.^®  The physicians on this year’s list practice at Temple University Hospital, Temple University Hospital-Episcopal Campus, Jeanes Hospital, and Fox Chase Cancer Center.

PHILADELPHIA, PA (February 11, 2013)—Online registration is now available for a one-day, no-cost symposium at Fox Chase Cancer Center for high school students to learn about potential careers in medicine, nursing, science, information technology, and business administration. The Health Careers Symposium will take place on Saturday, March 23, from 8 a.m. – 4:30 p.m. in the Fox Chase auditorium (333 Cottman Avenue, Philadelphia).

Doylestown, PA (January 31, 2013)—The Bucks County Chapter of Fox Chase Cancer Center’s Board of Associates—a group of volunteers who support patient care and cancer research at Fox Chase—will be hosting an elegant gala called “April in Vienna” on April 20, 2013 at Spring Mill Manor (171 Jacksonville Road, Ivyland, PA).

PHILADELPHIA (January 14, 2013)—Fox Chase Cancer Center’s Office of Health Communications and Health Disparities (OHCHD) recently received a grant from the National Breast Cancer Foundation to fund community-based patient navigation services. The one year grant will allow the OHCHD to expand its current navigation program for women who are screened for breast cancer on Fox Chase’s mobile mammography van and receive abnormal results. The vitally needed navigators will help those women obtain follow-up services at Fox Chase (or elsewhere if desired).

PHILADELPHIA, PA (January 14, 2013)—Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research from scientists at Fox Chase Cancer Center, published in the January issue of Cancer Discovery.

PHILADELPHIA, PA (January 14, 2013)—Breast cancer is the second leading cause of cancer deaths among women in the United States. Many of these deaths occur when there is an initial diagnosis of invasive or metastatic disease. A protein called NEDD9—which regulates cell migration, division and survival—has been linked to tumor invasion and metastasis in a variety of cancers. Researchers at Fox Chase Cancer Center have now shown that NEDD9 plays a surprising role in the early stages of breast tumor development by controlling the growth of progenitor cells that give rise to tumors.

PHILADELPHIA (January 7, 2013)—Fox Chase Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, is now offering patients with advanced cancer a cutting-edge clinical test that will provide them with a unique blueprint of their cancer genes.